Clinical Trials Directory

Trials / Completed

CompletedNCT05168969

Hyperekplexia in Patients With CTNNB1 Mutation

Hyperekplexia in Patients With Loss-of-function CTNNB1 Mutation

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A few years ago, a new genetic disorder (OMIM # 615075) has been associated with loss-of-function variations in the CTNNB1 gene. The clinical features include a delayed psychomotor development usually leading to severe intellectual disability with or without autistic spectrum disorders, progressive spastic diplegia, and various visual defects. Among over 30 cases described worldwide, 2 were reported with an exaggerated startle response to sudden stimulus corresponding to a very rare neurological phenomenon called hyperekplexia. The investigators also have a 3rd patient carrying a CTNNB1 syndrome associated with hyperekplexia.

Detailed description

Hyperekplexia can impair daily life because the affected person will fall unexpectedly and stiffly, causing repeated head- or body- wounds. It may be treated empirically by various drugs. Hyperekplexia has so far not been associated with CTNNB1 variations. In this study, we aim to describe the prevalence and clinical characteristics of hyperekplexia in CTNNB1 syndrome carriers, in order to improve diagnosis and thus treatment. The investigators will recruit CTNNB1 subjects through health care providers and also by contacting the families through dedicated social media and databases. The families and health care providers will be invited to fill in a questionnaire related to hyperekplexia (clinical, pharmacological, and genetic data).

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireThe families and health care providers will be invited to fill in a questionnaire related to hyperekplexia (clinical, pharmacological, and genetic data).

Timeline

Start date
2022-07-02
Primary completion
2022-12-10
Completion
2022-12-10
First posted
2021-12-23
Last updated
2023-04-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05168969. Inclusion in this directory is not an endorsement.